尿液中肌氨酸、PCA3mRNA在前列腺癌早期诊断中的应用

详细信息    查看全文 | 推荐本文 |

英文篇名：Application of Urinary Sarcosine and PCA3mRNA in Early Diagnosis of Prostate Cancer 作者：王乾 ; 孙宾 ; 李殷南 ; 沈俭 英文作者：WANG Qian;SUN Bin;LI Yin-nan;SHEN Jian;Department of Urology,Chongming Branch,Xinhua Hospital,Shanghai Jiaotong University School of Medicine; 关键词：肌氨酸 ; PCA3mRNA ; 前列腺癌 ; 早期诊断 英文关键词：SarcoEsine;;PCA3mRNA;;Prostate cancer;;Early diagnosis 中文刊名：YXXX 英文刊名：Medical Information 机构：上海交通大学医学院附属新华医院崇明分院泌尿外科; 出版日期：2019-07-15 出版单位：医学信息 年：2019 期：v.32;No.493 语种：中文; 页：YXXX201914059 页数：3 CN：14 ISSN：61-1278/R 分类号：183-185

摘要

目的探讨尿液中肌氨酸、PCA3mRNA,血清PSA在前列腺癌早期临床诊断中的应用。方法收集2016年9月～2017年12月在我院收治的前列腺增生患者62例以及前列腺癌患者62例(病理确诊)作为研究对象,前列腺癌患者为研究组,前列腺增生患者为对照组。以两组患者进行前列腺按摩后的初始尿液为标本,采用实时荧光定量对肌氨酸、PCA3mRNA,血清PSA进行检测,比较两组患者肌氨酸、PCA3mRNA,血清PSA的差异并统计两组患者的诊断准确度。结果研究组患者诊断准确度高于对照组,差异具有统计学意义(P<0.05);研究组患者尿肌氨酸、PCA3mRNA,血清PSA水平分别为(13.51±2.54)ng/ml、(6.09±0.56)ng/ml、(0.53±0.07)μmol/L,高于对照组的(7.60±0.27)ng/ml、(2.03±0.21)ng/ml、(0.36±0.04)μmol/L,差异具有统计学意义(P<0.05)。结论早期联合监测尿液中的肌氨酸、PCA3mRNA及血清PSA水平,可以提高前列腺癌的监测有效率,为患者提供更为便利的诊断手段。
        Objective To investigate the application of sarcosine, PCA3mRNA and serum PSA in the early diagnosis of prostate cancer. Methods A total of 62 patients with benign prostatic hyperplasia and 62 patients with prostate cancer(pathological diagnosis) were enrolled in our hospital from September 2016 to December 2017. The patients with prostate cancer were the study group and the patients with benign prostatic hyperplasia were the control group. The initial urine of the two groups of patients after prostate massage was used as the specimen. Real-time fluorescence quantification was used to detect sarcosine, PCA3mRNA and serum PSA. The differences of serum PSA between serum and PCA3mRNA were compared and the diagnostic accuracy of the two groups were statistically analyzed.Results The diagnostic accuracy of the study group was higher than that of the control group,the difference was statistically significant(P<0.05). The urinary creatinine, PCA3mRNA and serum PSA levels in the study group were(13.51±2.54) ng/ml,(6.09± 0.56) ng/ml,(0.53±0.07) μmol/L, higher than the control group(7.60±0.27) ng/ml,(2.03±0.21) ng/ml,(0.36±0.04) μmol/L,the difference was statistically significant(P<0.05).Conclusion Early monitoring of urinary creatinine, PCA3mRNA and serum PSA levels in urine can improve the efficiency of prostate cancer monitoring and provide a more convenient diagnostic tool for patients.

引文

[1]谭思嘉,许露伟,徐郑,等.PHI/PCA3在前列腺癌早期诊断中的应用价值探讨[J].中华医学杂志,2016,96(2):100-103.
    [2]张振奇,刘桂丽,张旭,等.尿PCA3评分对血清总PSA灰区前列腺癌患者的早期诊断价值[J].山东医药,2017,57(45):53-55.
    [3]段秀枝,陶志华.PCA3基因与前列腺癌的诊断及其应用价值研究[J].中华检验医学杂志,2016,39(8):568-570.
    [4]龚文容,刘继红.长链非编码RNA在泌尿系肿瘤中的研究进展[J].中华实验外科杂志,2016,33(12):2628-2631.
    [5]王美文,白文坤,胡兵.腹会阴联合切除术后前列腺穿刺活检的应用进展[J].中华超声影像学杂志,2016,52(1):87-89.
    [6]兰雨,何秀丽.经直肠超声引导下穿刺活检在前列腺癌诊断中的临床应用价值[J].解放军医学杂志,2016,41(5):416-419.
    [7]梅傲冰,张峻豪,贾本忠,等.前列腺癌中EPCA-2、PSA分子的表达及相关性[J].广东医学,2017,38(17):2658-2661.
    [8]章绪辉,梁文,全显跃,等.多模态MRI技术对早期前列腺癌的应用研究[J].中国临床医学影像杂志,2017,28(2):116-119.
    [9]马宇坤.PCA3检测在PSA灰区对前列腺癌诊断及病理分级的价值[D].山西医科大学,2017.
    [10]马悦,陈弋生.前列腺癌精准诊断的新进展[J].中华男科学杂志,2016,22(11):1030-1033.